Kuwait

Kuwait approves emergency use of Ronapreve to treat COVID-19

Kuwait approved the emergency use of Ronapreve, an antibody treatment developed by Regeneron and Roche, to prevent and treat COVID-19, Kuwait Times on Monday cited the health ministry as saying.

The drug has been shown to be effective in reducing the likelihood of COVID-induced hospitalizations, Kuwait’s Ministry of Health Assistant Undersecretary for drug control, Dr. Abdullah al-Bader, said, according to KT.

Ronapreve belongs to a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the body to fight off infections. The drug is not intended to be used as a substitute for vaccination, the MHRA said.

The decision came after a review of clinical trial data showed the drug may be used to prevent and treat acute COVID-19 infections, the KT reported.

Comments

Source
Al Arabiya

Related Articles

Back to top button